Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma ...Middle East

PR Newswire - News
Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma
LUND, Sweden, Sept. 1, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr. Hitto Kaufmann has been appointed as Hansa's Chief Scientific Officer (CSO) effective 1 December 2023....

Hence then, the article about dr hitto kaufmann appointed chief scientific officer of hansa biopharma was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma )

Apple Storegoogle play

Last updated :

Also on site :